Danish Pharmacovigilance Update, 19 January 2012

26 January 2012

In this issue of Danish Pharmacovigilance Update:

  • Patients treated with statins at risk of developing diabetes, front page
  • Proton-pump inhibitors (PPI) and risk of hypomagnesaemia with long-term use, front page
  • New Nordic study confirms a causal relationship between treatment with antidepressants of the SSRI type and increased risk of persistent pulmonary hypertension of the newborn (PPHN), page 2
  • Study of Rasilez® and Rasilez® HCT (aliskiren) was stopped early and has now triggered a review of efficacy and safety, page 3
  • Risk of depression from gonatropin-releasing hormone (GnRH) agonists, page 4
  • No evidence for increased risk of mortality in children treated with the growth hormone somatropin, page 4
  • Progressive multifocal leukoencephalopathy (PML) in connection with Tysabri® (natalizumab), page 5
  • Assessment of Articain® – an anaesthetic in dental treatment, page 5

Download the newsletter in the box to the right.

Did you get answers to your questions?

Please tell us how we can improve our website? Please note that we do not answer questions asked via this feature.